Home

Tutoring

Subjects

Live Classes

Study Coach

Essay Review

On-Demand Courses

Colleges

Games

Sign up

Log in

Opening subject page...

Loading your content

Practice

  • All Subjects
  • Algebra Flashcards
  • SAT Math Practice Tests
  • Math Question of the Day
  • Live Classes
  • On-Demand Courses

Varsity Tutors

  • Find a Tutor
  • Test Prep
  • Online Classes
  • K-12 Learning
  • College Search
  • VarsityTutors.com

© 2026 Varsity Tutors. All rights reserved.

← Back to quizzes

USMLE Step 1 Quiz

USMLE Step 1 Quiz: Ethics And Research Principles

Practice Ethics And Research Principles in USMLE Step 1 with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

Question 1 / 20

0 of 20 answered

A team of epidemiologists is investigating an outbreak of a foodborne illness linked to a specific restaurant. To identify the source, they need to access medical records of patrons who have recently eaten there and subsequently visited the emergency department. The investigation is deemed a public health emergency, and obtaining individual consent from each patient would cause critical delays in stopping the outbreak.

In this situation, an Institutional Review Board (IRB) or a similar ethics committee would likely grant which of the following?

Select an answer to continue

What this quiz covers

This quiz focuses on Ethics And Research Principles, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 1.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A team of epidemiologists is investigating an outbreak of a foodborne illness linked to a specific restaurant. To identify the source, they need to access medical records of patrons who have recently eaten there and subsequently visited the emergency department. The investigation is deemed a public health emergency, and obtaining individual consent from each patient would cause critical delays in stopping the outbreak.

In this situation, an Institutional Review Board (IRB) or a similar ethics committee would likely grant which of the following?

  1. A waiver of informed consent (correct answer)
  2. A conflict of interest exemption
  3. Permission to offer financial incentives
  4. Approval for an expedited review

Explanation: The correct answer is A. Federal regulations allow an IRB to waive the requirement for informed consent under specific circumstances. For public health activities, such as an outbreak investigation, a waiver is often justifiable because the research could not practicably be carried out without it, the research involves no more than minimal risk to subjects, and waiving consent will not adversely affect the rights and welfare of the subjects. The urgent need to identify the source and prevent further illness supports the waiver. B) A conflict of interest is not relevant to this scenario. C) Financial incentives are not the issue here; the problem is the impracticability of obtaining consent. D) While the review may be expedited, the key ethical provision required is the waiver of consent.

Question 2

A team of researchers is developing a novel chemotherapeutic agent for pancreatic cancer. They plan to conduct a randomized controlled trial comparing the new agent to the current standard-of-care chemotherapy. To be ethically justifiable, the researchers must have genuine uncertainty regarding the comparative therapeutic merits of each arm in the trial. They believe the new agent could be superior, but also acknowledge it may be equivalent or even inferior to the standard treatment.

Which of the following ethical principles is best illustrated by the researchers' state of uncertainty required to proceed with this trial?

  1. Beneficence
  2. Justice
  3. Clinical equipoise (correct answer)
  4. Respect for persons

Explanation: The correct answer is C. Clinical equipoise is the ethical principle that requires investigators to have genuine uncertainty about which arm of a clinical trial is superior. It is unethical to randomize a patient to a treatment known to be inferior. In this scenario, the researchers' uncertainty about whether the new agent is better, equivalent, or worse than the standard of care establishes clinical equipoise, making the randomized trial ethically permissible. A) Beneficence is the principle of 'doing good' and maximizing benefits while minimizing harm, which is related but not as specific as clinical equipoise in this context. B) Justice refers to the fair and equitable distribution of the burdens and benefits of research. D) Respect for persons involves recognizing the autonomy of individuals and protecting those with diminished autonomy, primarily upheld through the informed consent process.

Question 3

A pharmaceutical company is sponsoring a phase III clinical trial for a new antihypertensive medication. The principal investigator at one of the study sites holds a significant amount of stock in the company. During the study, the investigator notices a trend of slightly better blood pressure control in the active drug group but also a higher rate of minor adverse effects compared to the placebo. The investigator is responsible for assessing and reporting all adverse events.

This situation raises the most significant concern for which of the following ethical issues?

  1. Lack of clinical equipoise
  2. A conflict of interest (correct answer)
  3. Violation of patient confidentiality
  4. Inequitable subject selection

Explanation: The correct answer is B. A conflict of interest arises when a researcher's private interests, such as financial gain, may compete with their professional obligations to conduct objective research and ensure patient welfare. The principal investigator's stock ownership creates a financial incentive that could bias their judgment in data collection, interpretation, and reporting of adverse events, potentially compromising the integrity of the research and the safety of the participants. A) Clinical equipoise refers to the genuine uncertainty about the comparative effectiveness of the treatments being tested, which is not the primary issue described. C) There is no information in the vignette to suggest that patient confidentiality has been breached. D) Inequitable subject selection concerns the principle of justice and fair distribution of research burdens and benefits, which is not the main issue here.

Question 4

An Institutional Review Board (IRB) is reviewing a protocol for a study on the genetics of schizophrenia. The study involves collecting blood samples and detailed family histories from participants. The researchers plan to make the genetic data available to other qualified researchers through a public database to accelerate scientific discovery. The protocol includes a plan to de-identify the data by removing names and medical record numbers.

Which of the following represents the most significant ethical challenge the IRB must consider regarding the plan to share data?

  1. The potential for deductive re-identification of participants. (correct answer)
  2. The financial cost of maintaining the public database.
  3. The lack of a direct therapeutic benefit to the participants.
  4. The burden of blood collection on the participants.

Explanation: The correct answer is A. While de-identification by removing direct identifiers like names is a crucial step, genetic data is inherently unique. Combined with other information like detailed family history or demographic data, there is a risk of deductive re-identification, where a participant's identity could be inferred. This poses a significant risk to participant confidentiality and could lead to stigmatization or discrimination. The IRB must ensure that the data sharing plan includes robust protections to minimize this risk. B) Financial costs are a logistical, not an ethical, concern for the IRB. C) Lack of direct benefit is common in basic science research and is ethically acceptable as long as risks are minimized and participants are fully informed. D) The burden of blood collection is a risk to be considered, but the confidentiality risk associated with sharing genetic data is a more complex and significant challenge in this context.

Question 5

A multicenter clinical trial is testing a new drug for a life-threatening form of sepsis. An independent Data and Safety Monitoring Board (DSMB) is responsible for periodically reviewing the accumulating data. At the first interim analysis, the DSMB finds a statistically significant and clinically meaningful reduction in mortality in the group receiving the new drug compared to the standard care group. No significant safety concerns are identified.

Given these findings, which of the following actions is the DSMB most likely to recommend?

  1. Continue the trial as planned to increase statistical power.
  2. Stop the trial early due to demonstrated efficacy. (correct answer)
  3. Break the blind for the investigators but continue the trial.
  4. Add a third arm to the trial to test a different dosage.

Explanation: The correct answer is B. The primary role of a Data and Safety Monitoring Board (DSMB) is to protect the welfare of research participants. If an interim analysis provides clear and convincing evidence that one treatment is significantly more effective than another, it becomes unethical to continue randomizing participants to the inferior treatment arm. Therefore, the DSMB is likely to recommend stopping the trial early so that the superior treatment can be made available more broadly. A) Continuing the trial would ethically compromise the participants in the standard care group by denying them a proven superior treatment. C) Breaking the blind for investigators would introduce bias and is not the appropriate action when clear efficacy is shown. D) Modifying the trial protocol in this way is not the primary response to a definitive finding of efficacy.

Question 6

Researchers are conducting a study on a new treatment for severe depression in a local prison. The protocol offers inmates a small monetary compensation for their time, equivalent to what they might earn from a prison job. The consent form clearly states that participation is voluntary and will not affect their parole status or quality of care. The study has been approved by the appropriate institutional review board.

The involvement of prisoners in this research requires special ethical consideration primarily because this population is considered vulnerable to which of the following?

  1. Exploitation (correct answer)
  2. Physical harm
  3. Breaches of confidentiality
  4. Therapeutic misconception

Explanation: The correct answer is A. Prisoners are considered a vulnerable population in research ethics because their incarceration inherently curtails their autonomy and freedom. This creates a risk that they may feel coerced or unduly influenced to participate, for instance, by the hope of preferential treatment or out of boredom, making them susceptible to exploitation. Federal regulations (45 CFR 46, Subpart C) provide additional protections for prisoners as research subjects to mitigate this risk. B) While physical harm is a risk in any study, it is not the primary reason prisoners are a specially protected class. C) Confidentiality is an important consideration for all participants, not just prisoners. D) Therapeutic misconception (the belief that the primary purpose of research is to provide personal treatment) can affect any participant, not just prisoners.

Question 7

A researcher plans to conduct a study that involves analyzing existing, de-identified patient data from a hospital registry to look for correlations between certain lab values and patient outcomes. The researcher will not have access to any patient identifiers, and the data cannot be linked back to individual patients. The researcher submits the study protocol to the Institutional Review Board (IRB).

Which of the following is the most likely determination the IRB will make regarding this study protocol?

  1. The study requires a full board review.
  2. The study is exempt from IRB review. (correct answer)
  3. The study requires an expedited review.
  4. The study requires individual informed consent from all patients in the registry.

Explanation: The correct answer is B. Research involving the collection or study of existing data is eligible for exemption from IRB review and the requirement for informed consent if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects. Since the researcher is only using de-identified data and cannot link it back to individuals, the study poses no more than minimal risk and qualifies for an exemption. A) Full board review is for studies with greater than minimal risk. C) Expedited review is for minimal risk studies that do not qualify for exemption. D) Requiring informed consent would be necessary if identifiable private information were being used.

Question 8

A research group conducted a large, well-designed randomized controlled trial of a new drug intended to improve cognitive function in elderly patients. The results showed no statistically significant difference between the drug and a placebo. Furthermore, the drug group experienced a slightly higher rate of gastrointestinal side effects. The pharmaceutical company that funded the study is pressuring the investigators not to publish the findings.

The ethical obligation to publish the results of this study is primarily based on which of the following principles?

  1. Avoiding the waste of research resources and respecting participant contributions (correct answer)
  2. Protecting the pharmaceutical company's proprietary information
  3. Ensuring that only positive, clinically useful results enter the literature
  4. Maintaining the principal investigator's funding relationship with the company

Explanation: The correct answer is A. There is a strong ethical obligation to publish the results of clinical trials, regardless of the outcome. This is based on several principles. First, it respects the contribution and altruism of the participants who exposed themselves to risk. Second, it prevents 'publication bias,' where the medical literature becomes skewed towards positive findings. Third, it prevents other researchers from wasting resources and exposing future participants to the risks of studying a drug that has already been shown to be ineffective or harmful. Suppressing negative results is a form of scientific misconduct. B, C, and D all represent unethical considerations that conflict with the primary ethical duty to disseminate research findings honestly.

Question 9

A researcher is conducting a study on a sensitive topic: illegal drug use among college students. To encourage honest reporting, the researcher plans to use an anonymous survey. However, to track response rates, the survey software will automatically collect the IP addresses of the computers used to complete the survey.

The collection of IP addresses compromises which of the following ethical protections promised to the participants?

  1. Anonymity (correct answer)
  2. Beneficence
  3. Justice
  4. Informed consent

Explanation: The correct answer is A. Anonymity means that there is no way for anyone, including the researcher, to link the research data to a specific individual. Confidentiality means the researcher can link the data to an individual but promises not to disclose that link. By collecting IP addresses, which can potentially be traced to an individual or location, the study is no longer truly anonymous. This is a critical ethical failure, especially given the sensitive and illegal nature of the topic being studied, as it places participants at risk. B) Beneficence (maximizing good) and C) Justice (fairness) are not the primary principles compromised here. D) The informed consent process would be flawed because it inaccurately promised anonymity, but the core protection that has been violated is anonymity itself.

Question 10

During a genetics study on hereditary colon cancer, a researcher analyzes DNA from a father, mother, and child to track the inheritance of a specific gene mutation. The analysis incidentally reveals that the presumed father is not the biological father of the child. This finding of non-paternity is not related to the primary research question.

Which of the following is the most ethically complex issue the researcher must immediately address regarding this incidental finding?

  1. Whether to report the finding to the family. (correct answer)
  2. How to publish the finding without identifying the family.
  3. Whether to re-run the genetic analysis to confirm the result.
  4. How to adjust the statistical analysis for the study.

Explanation: The correct answer is A. The discovery of an incidental finding with significant psychosocial implications, such as non-paternity, creates a major ethical dilemma. The researcher must consider the potential harm of disclosing this information (e.g., family disruption, distress) against a potential duty to return individual research results. Research protocols for genetic studies should have a pre-specified plan for how to handle such findings, including whether and how they will be disclosed to participants. There is no easy answer, and it involves balancing principles of beneficence, non-maleficence, and autonomy. B) Publishing this specific finding is not the immediate ethical priority. C) While confirming the result is a good scientific practice, the ethical dilemma of what to do with the information remains. D) The statistical analysis is a secondary, technical concern compared to the ethical duty to the participants.

Question 11

A study is planned to test a new medication for preventing migraines. The current standard of care is an existing, effective medication, but it has some side effects. The researchers propose a randomized trial with three arms: the new medication, the standard medication, and a placebo. The study will enroll patients with frequent, severe migraines.

The inclusion of a placebo arm in this trial is ethically problematic because it conflicts with the principle that participants should not be denied which of the following?

  1. Access to a known effective therapy (correct answer)
  2. The opportunity to contribute to science
  3. Financial compensation for their participation
  4. Complete anonymity during the study

Explanation: The correct answer is A. It is generally considered unethical to use a placebo control group when a known, effective therapy exists for a condition, especially a serious one. Denying participants an effective treatment and giving them a placebo exposes them to preventable harm (in this case, continued severe migraines). The Declaration of Helsinki states that a new intervention should be tested against the current best proven intervention. A placebo arm might be justified only if there is no standard treatment or if there are compelling scientific reasons and the condition is not serious or life-threatening. B, C, and D are not the primary ethical principles violated by the use of a placebo in this context.

Question 12

A junior researcher is working in a lab where a major clinical trial is being analyzed. She notices that her principal investigator (PI) has removed several data points from the final analysis. When she asks why, the PI says, "Those were outliers and were messing up the statistical significance of our results." The junior researcher checks the original data and the study protocol and finds no pre-specified criteria for excluding outliers.

The principal investigator's action is an example of which of the following forms of research misconduct?

  1. Plagiarism
  2. Conflict of interest
  3. Falsification (correct answer)
  4. Breach of confidentiality

Explanation: The correct answer is C. Research misconduct is broadly defined as fabrication, falsification, or plagiarism. Falsification is manipulating research materials, equipment, or processes, or changing or omitting data or results such that the research is not accurately represented in the research record. By selectively removing data points that do not support the desired outcome without a valid, pre-specified justification, the PI is falsifying the results. A) Plagiarism is using another's work without credit. B) A conflict of interest is a situation that could bias judgment, but the action itself is falsification. D) There is no indication of a breach of confidentiality.

Question 13

Researchers are conducting a study in a low-income country on a new, inexpensive antibiotic for treating a common form of pneumonia. The study is funded by a US-based pharmaceutical company. If the drug is proven effective, it will be marketed in the US and Europe at a high price, but there are no provisions in the study protocol to ensure that the drug will be made available and affordable to the population of the host country after the trial concludes.

This scenario raises a significant ethical concern related to the principle of justice, specifically regarding which of the following issues?

  1. The risk of coercion of participants
  2. The lack of post-trial access to beneficial treatment (correct answer)
  3. The failure to obtain individual informed consent
  4. The potential for physical harm from the antibiotic

Explanation: The correct answer is B. The principle of justice requires that the benefits and burdens of research be distributed equitably. In this case, the population of the low-income country is bearing the burdens and risks of the research. However, if the benefits of that research (the effective drug) are not made reasonably available to them after the trial, they have been exploited for the benefit of wealthier populations. This is a key concern in international research, and ethical guidelines increasingly call for provisions for post-trial access. A, C, and D are all important ethical considerations in any trial, but the core issue of justice highlighted by the vignette is the lack of post-trial access.

Question 14

A physician-scientist is recruiting patients from her own clinic for a study she is conducting. When discussing the study with a potential participant, she says, "I am conducting a study to see if this experimental drug works. I think it could really help you, and it's important that we find better treatments." She then provides a 20-page consent form and asks the patient to sign it.

The physician's statement, "I think it could really help you," has the potential to create which of the following ethical problems?

  1. Violation of privacy
  2. Therapeutic misconception (correct answer)
  3. Scientific misconduct
  4. Selection bias

Explanation: The correct answer is B. Therapeutic misconception occurs when research participants fail to distinguish between the goals of clinical research and ordinary clinical care. The primary goal of research is to produce generalizable knowledge, not to provide individualized treatment. The physician's statement emphasizes the potential personal benefit, which may lead the patient to incorrectly believe they are receiving a personalized treatment rather than participating in an experiment. This can compromise the validity of their informed consent. A) There is no indication of a privacy violation. C) Scientific misconduct involves fabrication, falsification, or plagiarism, which is not depicted here. D) Selection bias relates to how subjects are chosen for a study, not how consent is obtained.

Question 15

A phase I clinical trial is designed to test the safety and determine the maximum tolerated dose of a new oncology drug. The trial enrolls patients with advanced, metastatic cancer who have exhausted all standard treatment options. The informed consent form accurately states that the primary purpose of the study is to assess safety and that a direct therapeutic benefit is unlikely, although possible.

The principle of beneficence in this context requires the researchers to primarily focus on which of the following?

  1. Maximizing the chance of a cure for each participant.
  2. Minimizing the risks and harms to the participants. (correct answer)
  3. Ensuring the results are published quickly.
  4. Recruiting a large number of participants to ensure statistical power.

Explanation: The correct answer is B. The principle of beneficence involves maximizing potential benefits and minimizing potential harms. In a phase I trial, the potential for direct therapeutic benefit to the participant is low and uncertain. Therefore, the primary application of beneficence is to minimize the risks associated with the experimental drug. This includes careful dose escalation, intensive monitoring for toxicity, and clear stopping rules to protect participants from undue harm. A) Maximizing the chance of a cure is not the primary goal of a Phase I trial; safety is the main objective. C) While publication is important, it is not the primary application of beneficence during the conduct of the trial. D) Phase I trials are typically small and are not designed for statistical power regarding efficacy.

Question 16

An Institutional Review Board (IRB) is a committee established to review and approve research involving human subjects. The primary purpose of the IRB is to ensure that all human subject research be conducted in accordance with all federal, institutional, and ethical guidelines.

To ensure a balanced review of research, federal regulations mandate that the composition of an IRB must include which of the following?

  1. At least one member who is not affiliated with the institution. (correct answer)
  2. Only members with doctoral degrees in science or medicine.
  3. A representative from the sponsoring pharmaceutical company.
  4. An equal number of male and female members.

Explanation: The correct answer is A. Federal regulations (45 CFR 46) require that an IRB have at least five members with varying backgrounds. To promote independence and ensure community perspectives are considered, the regulations mandate that at least one member must not be otherwise affiliated with the institution (a 'community member' or 'unaffiliated member'). This member provides a perspective that is not influenced by institutional pressures. B) The IRB must have members from diverse backgrounds, including non-scientists. C) Including a representative from a sponsor would create a significant conflict of interest. D) While diversity is required, a strict gender balance is not mandated.

Question 17

A research study is designed to test the efficacy of a new behavioral therapy for anxiety in adolescents aged 14-17. The researchers approach potential participants and their parents at a local clinic. After explaining the study to both the parent and the adolescent, the parent provides written permission for their child to participate. However, the 15-year-old adolescent clearly states that they do not want to be in the study.

According to ethical guidelines for research involving minors, which of the following is the most appropriate next step?

  1. Enroll the adolescent based on parental permission.
  2. Exclude the adolescent from the study. (correct answer)
  3. Request a second opinion from the adolescent's primary care physician.
  4. Proceed with enrollment but monitor the adolescent for increased distress.

Explanation: The correct answer is B. When conducting research with minors who are old enough to comprehend the study, it is ethically required to obtain their assent in addition to the permission of their parents or legal guardians. Assent is the minor's affirmative agreement to participate. If a minor with decisional capacity refuses to provide assent, their decision must be respected, and they should not be enrolled in the study, even if a parent has given permission. This respects the developing autonomy of the adolescent. A) Enrolling the adolescent would violate the ethical requirement for assent. C) While physician consultation can be useful, it does not override the adolescent's refusal to assent. D) Proceeding with enrollment despite the adolescent's refusal is unethical.

Question 18

Researchers are conducting a randomized trial for a new surgical procedure for knee pain. Participants in the control group will undergo a "sham" surgery, where an incision is made, but the therapeutic procedure is not performed. All participants are informed of the possibility of receiving the sham surgery. The goal is to control for the placebo effect associated with undergoing a surgical experience.

The use of a sham surgery control group raises the most direct ethical concerns related to which of the following principles?

  1. Justice
  2. Respect for persons
  3. Non-maleficence (correct answer)
  4. Confidentiality

Explanation: The correct answer is C. The principle of non-maleficence requires that researchers 'do no harm.' A sham surgery, even if minimally invasive, exposes participants to the risks of a procedure—such as infection, anesthesia complications, and post-operative pain—without any potential for therapeutic benefit. The IRB must carefully weigh whether these risks are justified by the scientific value of the study and whether they have been minimized as much as possible. A) Justice relates to the fair selection of subjects. B) Respect for persons is primarily addressed by ensuring participants are fully informed and consent voluntarily, which appears to be the case here. D) Confidentiality is not the primary ethical concern with this type of intervention.

Question 19

A research study aims to evaluate the effectiveness of a new vaccine for a novel influenza virus. The study plans to enroll healthy adult volunteers from the general community. The published recruitment materials exclusively target affluent, suburban neighborhoods, and all study visits are scheduled during standard weekday business hours, making it difficult for hourly wage earners to participate.

This recruitment strategy is most concerning for violating which of the following principles of research ethics?

  1. Beneficence
  2. Non-maleficence
  3. Justice (correct answer)
  4. Autonomy

Explanation: The correct answer is C. The principle of Justice, as described in the Belmont Report, requires the equitable selection of subjects. This means that the burdens and benefits of research should be distributed fairly. By targeting only affluent neighborhoods and having inconvenient appointment times, the study systematically excludes certain socioeconomic groups. This leads to a non-representative sample and places the burdens of research (e.g., risks of the vaccine) on one group while the benefits (a vaccine for a common illness) will be for all of society. A) Beneficence refers to maximizing benefits and minimizing harms. B) Non-maleficence means 'do no harm'. D) Autonomy refers to respecting individuals' capacity for self-determination, primarily through informed consent. While related, the core issue here is fairness in selection.

Question 20

A 72-year-old man with a recent diagnosis of mild cognitive impairment is invited to participate in a clinical trial for a new Alzheimer's disease medication. His adult daughter is his legally authorized representative. The researcher explains the study to both the patient and his daughter. The patient seems to understand parts of the explanation but has difficulty retaining the information about risks and alternatives.

To ethically enroll this patient, the researcher must obtain informed consent from the daughter and which of the following from the patient?

  1. A signature on the consent form
  2. Assent, to the extent of his ability (correct answer)
  3. A verbal commitment to complete the study
  4. A neuropsychological evaluation of his capacity

Explanation: The correct answer is B. For adults with diminished capacity, the ethical principle of respect for persons requires that researchers seek their assent to participate in research, in addition to obtaining informed consent from their legally authorized representative. Assent is a person's affirmative agreement to participate, and it should be sought even if the individual cannot provide legally valid informed consent. It respects their autonomy to the greatest extent possible. Refusal to assent should generally be honored. A) A signature without understanding does not constitute valid consent or assent. C) A commitment to complete the study is not the core ethical requirement for enrollment. D) While an evaluation of capacity is important for determining who should provide consent, it is the patient's assent that is also required.